The Role of Medical Therapy in Management of Bicuspid Aortic Valve–Associated Aortopathy in Children
Pharmacologic treatment was not associated with a meaningful reduction of AscAo and SoV dilatation rates in children with BAV.
Authors
- Louis-Olivier Roy (ORCID: https://orcid.org/0009-0008-0840-5447)
- Nagib Dahdah (ORCID: https://orcid.org/0000-0001-7715-3169)
- Santokh Dhillon (ORCID: https://orcid.org/0000-0001-9922-3981)
- Arif Hussain (ORCID: https://orcid.org/0000-0002-0851-4845)
- Andrew S. Mackie (ORCID: https://orcid.org/0000-0001-6126-1130)
- Joshua Penslar
- Derek Wong (ORCID: https://orcid.org/0000-0002-1208-6249)
- Michael Grattan (ORCID: https://orcid.org/0000-0002-6698-9232)
- Frédéric Dallaire (ORCID: https://orcid.org/0000-0002-0489-2523)
- Shreya Moodley (ORCID: https://orcid.org/0000-0002-5129-944X)
- Tíscar Cavallé-Garrido
- H. Alfuraian
- Christine Houde
Institutions
- Dalhousie University (CA)
- Children's Hospital of Eastern Ontario (CA)
- Montreal Children's Hospital (CA)
- Izaak Walton Killam Health Centre (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Centre hospitalier universitaire de Québec (CA)
- Children's Hospital of Western Ontario (CA)
- BC Children's Hospital (CA)
- Le Bonheur Children's Hospital (US)
- Stollery Children's Hospital (CA)
- Imam Abdulrahman Bin Faisal University (SA)
Publication Details
- Journal
- CJC Pediatric and Congenital Heart Disease
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1016/j.cjcpc.2024.11.003
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00